Why data sovereignty is no longer optional for European pharma companies — and how your CRM choice directly impacts it
In today’s highly regulated and increasingly complex digital landscape, selecting the right Pharma CRM system is no longer just a technical choice. For European pharmaceutical companies, it is a strategic decision that influences compliance, patient safety, data integrity, and long-term competitiveness.
Our latest playbook, Pharma CRM 2025: Your Guide to Choosing a Secure, Compliant and Sovereign Solution, explores how evolving regulations and geopolitical shifts are reshaping the CRM landscape—and what pharma businesses must do to adapt.
Inside the guide, you’ll discover:
-
Why reliance on U.S.-based cloud providers may conflict with GDPR
-
How the CLOUD Act exposes European data to extraterritorial access
-
What GAIA-X and the EU Data Act mean for future data governance
-
The seven critical questions every pharma company should ask when evaluating CRM platforms
-
How to align your CRM strategy with vertical specialization and digital sovereignty
This playbook is designed for pharmaceutical leaders, compliance teams, and IT strategists looking to make informed, future-ready decisions.
Download the playbook below to explore how you can protect your data, ensure compliance, and build a resilient digital foundation.
Pharma CRM 2025 Your Guide to Choosing a Secure, Compliant and Sovereign Solution